# Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma

> **NCT00230451** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center**

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** Radiation
- **DRUG:** Paclitaxel
- **DRUG:** Cisplatin
- **DRUG:** 5-Fluorouracil

## Key facts

- **NCT ID:** NCT00230451
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** 1999-12
- **Final completion:** 2008-07
- **Target enrollment:** — (—)
- **Last updated:** 2010-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230451, "Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00230451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*